Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Gatipotuzumab |
| Trade Name | |
| Synonyms | pankomab|pankoMab-GEX |
| Drug Descriptions |
Gatipotuzumab is a humanized monoclonal antibody targeting tumor-associated MUC1, which potentially induces antibody-dependent cellular cytotoxicity (ADCC) and tumor cell death (PMID: 16485130). |
| DrugClasses | MUC1 Antibody 8 |
| CAS Registry Number | 1264737-26-9 |
| NCIT ID | C94220 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Gatipotuzumab | Gatipotuzumab | 0 | 0 |
| Gatipotuzumab + Tomuzotuximab | Gatipotuzumab Tomuzotuximab | 0 | 0 |